The purpose of Developing Markets Series is to examine prospects for the growth of pharmaceutical revenues in the developing economies of Asia
May 1, 2007 (Press Release) --
The purpose of Developing Markets Series is to examine prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe in three linked reports. Central and Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011 - Part 3 of Developing Markets - discusses prospects for the large developing market of Central and Eastern Europe. The other reports discuss Asia and Latin America respectively. Importantly, the growth of pharmaceutical markets in economically developing nations has the potential to offset serious problems currently being experienced by the global industry. The purpose of this report is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Central and Eastern Europe, at both regional and national level.
The growth of pharmaceutical markets in the developing nations has the potential to offset serious problems currently experienced by the global industry. The principal challenge is slow growth in North America, Western Europe and Japan.
In contrast, it predicts that all the leading developing markets will exhibit strong growth from 2006-2011. Rapid economic growth and large, under-served populations will drive that expansion. There will be significant growth in sales of both branded and generic drugs through increasing demand from both public and private healthcare sectors.
Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011, examines developing pharmaceutical markets critically through comprehensive research and analysis. It applied techniques such as financial forecasting, SWOT analyses and discussion of qualitative factors. Societal, political, economic and commercial issues are covered. The result is a comprehensive market-based report with detailed analysis and informed opinion.
In particular, Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011, concentrates on the following themes :
A forecast of the global pharmaceutical market from 2006-2011, with key issues discussed
Forecasts of sales revenues and growth rates for leading developing markets in Central and Eastern Europe from 2006-2011
Drivers and opportunities in those markets
Restraints and threats in those markets
Discussion of key players and important therapeutic areas
Discussion of relevant regulatory, societal and economic issues
Comparison of the prospects for revenue generation in Asia, Latin America and Central/Eastern Europe, with overall forecasts for those regions
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=40505
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
The growth of pharmaceutical markets in the developing nations has the potential to offset serious problems currently experienced by the global industry. The principal challenge is slow growth in North America, Western Europe and Japan.
In contrast, it predicts that all the leading developing markets will exhibit strong growth from 2006-2011. Rapid economic growth and large, under-served populations will drive that expansion. There will be significant growth in sales of both branded and generic drugs through increasing demand from both public and private healthcare sectors.
Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011, examines developing pharmaceutical markets critically through comprehensive research and analysis. It applied techniques such as financial forecasting, SWOT analyses and discussion of qualitative factors. Societal, political, economic and commercial issues are covered. The result is a comprehensive market-based report with detailed analysis and informed opinion.
In particular, Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011, concentrates on the following themes :
A forecast of the global pharmaceutical market from 2006-2011, with key issues discussed
Forecasts of sales revenues and growth rates for leading developing markets in Central and Eastern Europe from 2006-2011
Drivers and opportunities in those markets
Restraints and threats in those markets
Discussion of key players and important therapeutic areas
Discussion of relevant regulatory, societal and economic issues
Comparison of the prospects for revenue generation in Asia, Latin America and Central/Eastern Europe, with overall forecasts for those regions
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=40505
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
Email
Print
SPAM
LEAVE A COMMENT
